Citation Impact
Citing Papers
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Cortisol Circadian Rhythm Alterations in Psychotic Major Depression
2006
Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression
2005
Anna-Monika Award Lecture, DGPPN Kongress, 2013: The role of the hypothalamic–pituitary–adrenal (HPA) axis in the pathogenesis of psychotic major depression
2014
Major depressive disorder
2016 Standout
The Natural History of Neuroendocrine Changes in Pediatric Posttraumatic Stress Disorder (PTSD) After Motor Vehicle Accidents: Progressive Divergence of Noradrenaline and Cortisol Concentrations Over Time
2007
The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis
2018 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
HPA axis hyperactivity as suicide predictor in elderly mood disorder inpatients
2008
Modulation of the mineralocorticoid receptor as add-on treatment in depression: A randomized, double-blind, placebo-controlled proof-of-concept study
2009
The use of the elevated plus maze as an assay of anxiety-related behavior in rodents
2007 Standout
Optimal therapy for Helicobacter pylori infections
2011
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Sex differences in HPA axis responses to stress: a review
2004 Standout
The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner
2012 Standout
Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research.
2016 Standout
Cerebrospinal Fluid Corticotropin-Releasing Factor Concentration is Associated with Pain but not Fatigue Symptoms in Patients with Fibromyalgia
2006
The age of anxiety: role of animal models of anxiolytic action in drug discovery
2011
Corticosteroids mediate fast feedback of the rat hypothalamic-pituitary-adrenal axis via the mineralocorticoid receptor
2008
Corticotropin-releasing factor receptor-1: a therapeutic target for cardiac autonomic disturbances
2007
The Role of Glutamate in Anxiety and Related Disorders
2005
The HPA axis in major depression: classical theories and new developments
2008 Standout
Strength and vulnerability integration: A model of emotional well-being across adulthood.
2010 Standout
Mineralocorticoid Receptor Stimulation Improves Cognitive Function and Decreases Cortisol Secretion in Depressed Patients and Healthy Individuals
2014
Major Depressive Disorder
2008 Standout
Stress and disorders of the stress system
2009 Standout
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
2007 Standout
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia
2005
A meta-analysis of cortisol response to challenge in human aging: importance of gender
2004
Mental Depression and Cardiovascular Disease: A Multifaceted, Bidirectional Association
2009
Antiglucocorticoid treatments for mood disorders
2015
Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy
2006
Social and Emotional Aging
2009 Standout
Works of Josef Arlt being referenced
Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection?
2001
The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone
2003
Effects of a metabotropic glutamate2/3 receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results
2004
Modulation of sympathetic activity by corticotropin-releasing hormone and atrial natriuretic peptide
2003
Longitudinal course of salivary cortisol in post‐traumatic stress disorder
2002
Preliminary results of a prospective, double-blind, placebo controlled study of metyrapone as an adjunct in the treatment of major depression
2002